Muscle triglyceride and insulin resistance

Annual Review of Nutrition

Volumn 22, Issue , 2002, Pages 325-346

  Kelley, David E ^a   Goodpaster, Bret H ^a   Storlien, Len ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Fatty acids; Insulin resistance; Obesity; Phospholipids; Skeletal muscle; Triglyceride; Type 2 diabetes mellitus

Indexed keywords

LEPTIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; ENERGY; FATTY ACID OXIDATION; GLYCOGEN METABOLISM; HUMAN; INSULIN RESISTANCE; LIPID ABSORPTION; LIPID STORAGE; MUSCLE FIBER MEMBRANE CONDUCTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; NUTRITIONAL REQUIREMENT; OBESITY; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADIPOSE TISSUE; DIABETES MELLITUS, TYPE 2; GLYCOGEN; HUMANS; INSULIN RESISTANCE; LEPTIN; MUSCLE, SKELETAL; OBESITY; TRIGLYCERIDES;

EID: 0036399825     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.22.010402.102912     Document Type: Review

References (96)

1. Abu-Elheiga L, Matzuk MM, Abo-Hashema KAH, Wakil SJ. 2001. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291:2613-16
2. Andres R, Cader G, Zierler K. 1956. The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state. Measurement of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm. J. Clin. Invest. 35:671-82
3. Baltzan M, Andres R, Cader G, Zierler K. 1962. Heterogeneity of forearm metabolism with special reference to free fatty acids. J. Clin. Invest. 41:116-25
4. Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA, Saris WH. 1994. Beta-adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men. Am. J. Physiol. Endocrinol. Metab. 267:E316-E22
5. Blaak EE, Wagenmakers AJM, Glatz JFC, Wolffenbuttel BHR, Kemerink GJ, et al. 2000. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am. J. Physiol. 279:146-54
6. Boden G, Jadali F, White J, Liang Y, Mozzoli M, et al. 1991. Effect of fat on insulin-stimulated carbohydrate metabolism in normal men. J. Clin. Invest. 88:960-66
7. Boden G, Lebed B, Schatz M, Homko C, Lemieux S. 2001. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50:1612-17
8. Boesch C, Slotboom J, Hoppeler H, Kreis R. 1997. In vivo determination of intramyocellular lipids in human muscle by means of localized 1H-R-spectroscopy. Magn. Reson. Med. 37:484-93
9. Bogardus C, Lillioja S, Stone K, Mott D. 1984. Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J. Clin. Invest. 73:1185-90
10. Bonen A, Luiken JJ, Liu S, Dyck DJ, Kiens B, et al. 1998. Palmitate transport and fatty acid transporters in red and white muscles. Am. J. Physiol. Endocrinol. Metab. 275: E471-E78
11. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. 1993. The relationship between insulin sensitivity and the fatty acid composition of phospholipids of skeletal muscle. N. Engl. J. Med. 328:238-44
12. Boss O, Bobbioni-Harsch E, Assimacopooulos-Jeannet F, Muzzin P, Murger R, et al. 1998. Uncoupling protein-3 expression in skeletal muscle and free fatty acids in obesity. Lancet 351:1933-39
13. Budohoski L, Gorski J, Nazar K, Kaciuba-Uscilko H, Terjung RL. 1996. Triacylglycerol synthesis in the different skeletal muscle fiber sections of the rat. Am. J. Physiol. Endocrinol. Metab. 271(34):E574-E81
14. Buettner R, Newgard CB, Rhodes CJ, O'Doherty RM. 2000. Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia. Am. J. Physiol. Endocrinol. Metab. 278:E563-E69
15. Colberg SR, Simoneau J-A, Thaete LF, Kelley DE. 1995. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J. Clin. Invest. 95:1846-53
16. Dagenais G, Tancredi R, Zierler K. 1976. Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm. J. Clin. Invest. 58:421-31
17. Décombaz, J, Schmitt B, Ith M, Decarli B, Diem P, et al. 2001. Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 281:R760-R69
18. Dobbins RL, Szczepaniak LS, Bentley B, Esser V, Myhill J, McGarry JD. 2001. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 50:123-30
19. Ducluzeau P-H, Perretti N, Laville M, Andreelli F, Vega N, et al. 2001. Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Diabetes 50:1134-42
20. Dyck DJ, Peters SJ, Glatz J, Gorski J, Keizer H, et al. 1997. Functional differences in lipid metabolism in resting skeletal muscle of various fiber types. Am. J. Physiol. Endocrinol. Metab. 272(35):E340-E51
21. Ellis BA, Poynten A, Lowy AJ, Furler SM, Chisholm DJ, et al. 2000. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am. J. Physiol. Endocrinol. Metab. 279:E554-E60
22. Else PL, Wu BJ. 1999. What role for membranes in determining the higher sodium pump molecular activity of mammals compared to ectotherms? J. Comp. Physiol. B 169:296-302
23. Evans K, Clark ML, Frayn KN. 2001. Carbohydrate and fat have different effects on plasma leptin concentrations and adipose tissue leptin production. Clin. Sci. 5:493-98
24. Faergman, NJ, Knudsen J. 1997. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and cell signaling. Biochem. J. 323:1-12
25. Felber JP, Ferrannini E, Golay A, Meyer H, Thiebaud D, et al. 1987. Role of lipid oxidation in the pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-50
26. Ferraro R, Eckel R, Larson E, Fontvielle A, Rising R, et al. 1993. Relationship between skeletal muscle lipoprotein lipase activity and 24-hour macronutrient oxidation. J. Clin. Invest. 92:441-45
27. Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R. 2000. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J. Appl. Physiol. 89:104-10
28. Goodpaster BH, Thaete FL, Kelley DE. 2000. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am. J. Clin. Nutr. 71:885-92
29. Goodpaster BH, Thaete FL, Simoneau J-A, Kelley DE. 1997. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46:1579-85
30. Goodpaster BH, Theriault R, Watkins SC, Kelley DE. 1999. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 49:467-72
31. Grimby G, Aniansson A, Zetterberg C, Saltin B. 1984. Is there a change in relative muscle fibre composition with age? Clin. Physiol. 4:189-94
32. Hajduch E, Balendran A, Batty IH, Litherland GJ, Blair AS, et al. 2001. Ceramide impairs the insulin-dependent membrane recruitment of Protein Kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 44:173-83
33. Hajduch E, Litherland GJ, Hundal HS. 2001. Protein kinase B (PKB/Akt): a key regulator of glucose transport? FEBS Lett. 492:199-203
34. Hannah VC, Ou J, Luong A, Goldstein JL, Brown MS. 2001. Unsaturated fatty acids down-regulate SREBP isoforms la and lc by two mechanisms in HEK-293 cells. J. Biol. Chem. 276:4365-72
35. Deleted in proof
36. He J, Watkins S, Kelley DE. 2001. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50:817-23
37. Helge JW, Fraser AM, Kriketos AD, Jenkins AB, Calvert GD, et al. 1999. Interrelationships between muscle fibre type, substrate oxidation and body fat. Int. J. Obes. 23:986-91
38. Hoppeler H, Howald H, Conley K, Lindstedt SL, Claasen H, et al. 1985. Endurance training in humans: Aerobic capacity and structure of skeletal muscle. J. Appl. Physiol. 59:320-27
39. Horton JD, Shimomura I. 1999. Sterol regulatory element-binding proteins: Activators of cholesterol and fatty acid biosynthesis. Curr. Opin. Lipidol. 10:143-50
40. James DE, Jenkins AB, Kraegen EW. 1985. Heterogeneity of insulin action in individual muscle in vivo: Euglycemic clamp studies in rats. Am. J. Physiol. Enclocrinol. Metab. 248:E567-E74
41. Kakuma T, Lee Y, Higa M, Wang Z-W, Pan W, et al. 2000. Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc. Natl. Acad. Sci. USA 97: 8536-41
42. Kelley DE, Goodpaster BH, Wing RR, Simoneau JA. 1999. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity and weight loss. Am. J. Physiol. Endocrinol. Metab. 40 (277):E1130-E41
43. Kelley DE, Mandarino LJ. 1990. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependendent diabetes mellitus. J. Clin. Invest. 86:1999-2007
44. Kelley DE, Mokan M, Simoneau J-A, Mandarino LJ. 1993. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J. Clin. Invest. 92:93-98
45. Kelley DE, Reilly J, Veneman T, Mandarino LJ. 1990. The influence of physiologic hyperinsulinemia on skeletal muscle glucose storage, oxidation and glycolysis in man. Am. J. Physiol. Endocrinol. Metab. 258(21):E923-E29
46. Kelley DE, Simoneau JA. 1994. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 94:2349-56
47. Kelley DE, Slasky S, Janosky J. 1991. Effects of obesity and non-insulin dependent diabetes mellitus. Am. J. Clin. Nutr. 54: 509-15
48. Kim JK, Kim Y-J, Fillmore JJ, Chen Y, Moore I, et al. 2001. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 108:437-46
49. Kriketos AD, Baur LA, O'Conner JO, Carey D, King S, et al. 1997. Muscle fibre type composition in infant and adult populations and relations with obesity. Int. J. Obes. 21:796-801
50. Kriketos AD, Pan DA, Lillioja S, Cooney GJ, Baur LA, et al. 1996. Interrelationships between muscle morpholgy, insulin action, and adiposity. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 270:R1332-R39
51. Krotkiewski M, Seidell JC, Björntorp P. 1990. Glucose tolerance and hyperinsulinaemia in obese women: Role of adipose tissue distribution, muscle fibre characteristics and androgens. J. Int. Med. 228:385-92
52. Levin K, Schroeder DH, Alford FP, Beck-Nielsen H. 2001. Morphonmetric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with type II diabetes. Diabetologia 44:824-33
53. Lillioja S, Bogardus C, Mott D, Kennedy A, Knowler W, Howard B. 1985. Relationship between insulin-mediated glucose disposal and lipid metabolism in man. J. Clin. Invest. 75:1106-15
54. Lillioja S, Young A, Culter C, Ivy J, Abbot W, et al. 1987. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J. Clin. Invest. 80:415-24
55. Malenfant P, Joanisse DR, Theriault R, Goodpaster BH, Kelley DE, Simoneau JA. 2001. Fat content in individual muscle fibers of lean and obese subjects. Int. J. Obes. 25:1316-21
56. Manco M, Mingrone G, Greco AV, Capristo E, Gniuli D, et al. 2000. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism 49:220-24
57. Mandarino LJ, Consoli A, Jain A, Kelley DE. 1996. Interaction of carbohydrate and fat fuels in human skeletal muscle: Impact of obesity and NIDDM. Am. J. Physiol. Endocrinol. Metab. 270(33):E463-E70
58. Matsuo T, Sumida H, Suzuki M. 1995. Beef tallow diet decreases B-adrenergic receptor binding and lipolytic activities in different adipose tissues of rat. Metabolism 44:1271-77
59. McGarry JD, Brown NF. 1997. The mitochondrial carnitine palmitoyltransferase system: From concept to molecular analysis. Eur. J. Biochem. 224:1-14
60. Muoio D, Dohm L, Tapscott EB, Coleman RA. 1999. Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/ob mice. Am. J. Physiol. 276:E913-E21
61. Nordfors L, Hoffstedt J, Nyberg B, Thorne A, Arner P, et al. 1998. Reduced gene expression of UCP2 but not UCP3 in skeletal muscle of human obese subjects. Diabetologia 41:935-39
62. Oakes ND, Bell KS, Furler SM, Camilleri S, Saha AK, et al. 1997. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: Parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA. Diabetes 46:2022-28
63. Pan DA, Lillioja S, Milner MR, Kriketos AD, Baur LA, et al. 1995. Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J. Clin. Invest. 96:2802-8
64. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, et al. 1999. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: A 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600-6
65. Phillips DW, Caddy S, Llic V, Frayn KN, Borthwick AC, Taylor R. 1996. Intramuscular triglycerides and muscle insulin sensitivity: Evidence for a relationship in nondiabetic subjects. Metabolism 45:947-50
66. Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR. 1985. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N. Engl. J. Med. 312:1210-16
67. Randle PJ, Garland PB, Hales CN, Newsholme EA. 1963. The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 785-89
68. Ruderman NB, Saha AK, Vavvas D, Witters LA. 1999. Malonyl-CoA, fuel sensing, and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 276:E1-E18
69. Schwarz J, Neese R, Turner S, Dare D, Hellerstein M. 1995. Short-term alterations in carbohydrate energy intake in humans: Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J. Clin. Invest. 96:2735-43
70. Segal K, Chatr-Aryamontri B, Rosenbaum M, Simoneau JA. 1995. Effects of hypertension and obesity on postprandial thermogenesis in men. Am. J. Clin. Nutr. 61: 895-901
71. Shimabukuro M, Koyama K, Chen G, Wang M-Y, Trieu F, et al. 1997. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. USA 94:4637-41
72. Shulman GI. 2000. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106:171-76
73. Sidossis LS, Stuart CA, Shulman GI, Lopaschuk GD, Wolfe RR. 1996. Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. J. Clin. Invest. 98:2244-50
74. Simoneau JA, Bouchard C. 1989. Human variation in skeletal muscle fiber type proportion and enzyme activities. Am. J. Physiol. Endocrinol Metab. 257:E567-E72
75. Simoneau JA, Kelley DE. 1997. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J. Appl. Physiol. 83:166-71
76. Simoneau JA, Kelley DE, Neverova M, Warden CH. 1998. Overexpression of muscle uncoupling protein-2 content in human obesity associates with reduced skeletal muscle lipid utilization. FASEB J. 12:1739-45
77. Simoneau J-A, Veerkamp JH, Turcotte LP, Kelley DE. 1999. Markers of capacity to utilize fatty acids in human skeletal muscle: Relation to insulin resistance and obesity and effects of weight loss. FASEB J. 13:2051-60
78. Simoneau J-A, Colberg SR, Thaete FL, Kelley DE. 1995. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J. 9:273-78
79. Steinberg GR, Dyck DJ. 2000. Development of leptin resistance in rat soleus muscle in response to high-fat diets. Am. J. Physiol. Endocrinol. Metab. 279:E1374-E82
80. Storlien LH, Hulbert AJ, Else PL. 1998. Polyunsaturated fatty acids, membrane function and diseases such as diabetes and obesity. Curr. Opin. Clin. Nutr. Metab. Care 1:559-63
81. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW. 1991. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and w-3 fatty acids in muscle phospholipids. Diabetes 40:280-89
82. Storz P, Döppler H, Wernig A, Pfizenmaier K, Müller G. 1999. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells: Palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake. Eur. J. Biochem. 266:17-25
83. Szcepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, et al. 1999. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am. J. Physiol. Endocrinol. Metab. 276:E977-E89
84. Vessby B, Tengblad S, Lithell H. 1990. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 37:1044-50, 1994
85. Wade A, Marbut M, Round J. 1990. Muscle fiber type and aetiology of obesity. Lancet 335:805-8
86. Wang J, Obici S, Morgan K, Barzilai N, Feng Z, Rossetti L. 2001. Overfeeding rapidly induces leptin and insulin resistance. Diabetes 50:2786-91
87. Wang N, Hikida RS, Staron RS, Simoneau JA. 1993. Muscle fiber types of women after resistance training - Quantitative ultrastructure and enzyme activity. Pflügers Arch. 424:494-502
88. Weintraub M, Zechner R, Brown A, Eisenberg S, Breslow J. 1988. Dietary polyunsaturated fats of the w-6 and w-3 series reduced postprandial lipoprotein levels. J. Clin. Invest. 82:1884-93
89. Winder WW, Arogyasami J, Elayan IM, Dartmill D. 1990. Time course of exercise-induced decline in malinoyl-CoA in different muscle types. Am. J. Physiol. Endocrinol. Metab. 259:E266-E71
90. Winder WW, MacLean PS, Lucas JC, Fernley JE, Trumble GE. 1995. Effect of fasting and refeeding on acetyl-CoA carboxylase in rat hindlimb muscle. J. Appl. Physiol. 78:578-82
91. Witters LA, Watts TD, Daniels DL, Evans JL. 1998. Insulin stimulates the dephosphorylation and activation of acetyl CoA carboxylase. Proc. Natl. Acad. Sci. 85:5473-77
92. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, et al. 2001. Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of IKKB. Science 293:1673-77
93. Zeghari N, Vidal H, Younsi M, Ziegler O, Drouin P, Donner M. 2000. Adipocyte membrane phospholipids and PPAR-g expression in obese women: Relationship to hyperinsulinemia. Am. J. Physiol. Endocrinol. Metab. 279:E736-E43
94. Zeghari N, Younsi M, Meyer L, Donner M, Drouin P, Ziegler O. 2000. Adipocyte and erythrocyte plasma membrane phospholipid composition and hyperinsulinemia: A study in nondiabetic and diabetic obese women. Int. J. Obes. 24:1600-7
95. Zurlo F, Lillioja S, Esposito-DelPuente A, Nyomba BL, Raz I, et al. 1990. Low ratio of fat to carbohydrate oxidation as a predictor of weight gain: A study of 24-h RQ. Am. J. Physiol. Endocrinol. Metab. 259 (22):E650-E57
96. Zurlo F, Nemeth PM, Choski RM, Sesodia S, Ravussin E. 1994. Whole body energy metabolism and skeletal muscle biochemical characteristics. Metabolism 43:481-86